Latest treatment news and information for patient advocates and people working in hepatitis in Europe. Find out more about infohep > A collaboration between www.elpa-info.org www.nam.org.uk The International Liver CongressThe International Liver Congress was held in London last week. Read the latest news.We'll be reporting on research presented there in the April edition of our news bulletin. Sign up to receive it! New! Hepatitis C treatment factsheetsIntroduction to three direct-acting antivirals. Customise your hepatitis informationThis simple tool tailors information to your interests. WHO guidelinesWHO recommends global use of newest hepatitis C drugs, urges price reductions. Hepatitis bulletinSign up for our free monthly hepatitis news bulletin. New to hepatitis?Read our introductory information on viral hepatitis > infohep news New Hepatitis delta Prolonged pegylated interferon plus tenofovir does not prevent hepatitis delta relapse Liz Highleyman / 10 hours ago Treating hepatitis B patients with hepatitis delta virus (HDV) coinfection using pegylated interferon plus tenofovir (Viread) for 96 weeks may reduce HDV viral load, but side effects are frequent and it did not significantly ... New Treatment in liver transplanted Three-drug AbbVie combination safe and highly effective in treatment of post-transplant hepatitis C recurrence Keith Alcorn / 10 hours ago A three-drug combination of direct-acting antivirals developed by AbbVie cured hepatitis C genotype 1 infection in 96% of transplant recipients with recurrent hepatitis C in a small phase II study reported last week ... Genotype 4 AbbVie 2-drug combination + ribavirin achieves 100% cure in previously untreated genotype 4 hepatitis C Keith Alcorn / 22 April 2014 A combination of two direct-acting antivirals developed by AbbVie cured 100% of previously untreated patients with hepatitis C genotype 4 infection when used with ribavirin, Christophe Hézode reported on Friday at the ... Cirrhosis AbbVie 3-drug combination cures 92 to 96% of hepatitis C patients with cirrhosis Keith Alcorn / 22 April 2014 The largest study of new direct-acting antivirals yet conducted in people with hepatitis C genotype 1 who have compensated cirrhosis has shown that it is possible to cure between 92 and 96% ... Treatment in liver transplanted Sofosbuvir + ribavirin is safe and effective for people with hepatitis C who have advanced liver disease Liz Highleyman / 17 April 2014 Sofosbuvir plus ribavirin is a safe option that can lead to sustained response in people with advanced liver disease including those with decompensated cirrhosis and portal hypertension, and people who experience severe hepatitis ... View all infohep news Editors' picks from other sources New AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C AbbVie press release / 12 hours ago New Gilead Beats Hepatitis C Sales Estimates by $1 Billion Bloomberg / 12 hours ago NHS England agrees funding for life-saving hepatitis C drug NHS England (press release) / 17 April 2014 England: Patients with end-stage liver disease caused by hepatitis C to get new drug The Guardian / 17 April 2014 Crimea: Russian Law Corners Drug Users Inter Press Service / 16 April 2014 The Global Drug Survey 2014 findings Global Drug Survey / 14 April 2014 No sofosbuvir patent in Egypt, but Gilead deal still expensive Third World Network / 14 April 2014 Viral hepatitis more deadly than HIV in Europe Science Daily / 14 April 2014 Does paying drug users boost hep B jab uptake? NHS Choices (Behind the Headlines) / 11 April 2014 Viral Hepatitis More Deadly Than HIV In Europe EASL / 11 April 2014 View all news from other sources Latest library resources Safer heroin injecting TypeWeb page Published2013 AuthorJon Derricott A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel [2012] TypeWeb page CountryRussian Federation, Turkey, Western and Central Europe Published2013 AuthorLiver International Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012 TypeWeb page CountryUnited States PublishedApril 2013 AuthorAmerican Association for the Study of Liver Diseases View all resources Looking for country specific news, resources and services?Visit our country information pages > Keep up to date with the latest hepatitis newsSign up for our free monthly email bulletin >